Key result
Transcatheter tricuspid valve replacement with LuX-Valve Plus reports 1-year compassionate use outcomes.
Key points are not available for this paper at this time.
International audience
No takes yet. Share an insight, caveat, or question.
Stolz et al. (2025) studied this question. Transcatheter tricuspid valve replacement using the LuX-Valve Plus system was evaluated for 1-year compassionate use outcomes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: